Prenatal high–dose immunoglobulin treatment for neonatal hemochromatosis: A case report and review of the literature

    loading  Checking for direct PDF access through Ovid

Abstract

Neonatal hemochromatosis is a difficult disorder to cure, and it has a high rate of recurrence. High–dose immunoglobulin treatment is very effective as prenatal treatment for recurrent neonatal hemochromatosis. A 34–year–old pregnant Japanese woman underwent high–dose immunoglobulin treatment for recurrent neonatal hemochromatosis. High–dose non–specific intravenous immunoglobulin (1 g/kg bodyweight) was administered to the mother intravenously every week from 18 until 36 gestational weeks. A male infant was delivered at 37 weeks of gestation, and his condition was favorable, including hepatic function. The use of γ–globulin for neonatal hemochromatosis appears adequately validated by experience.

Related Topics

    loading  Loading Related Articles